For the CY 2026 OPPS/ASC proposed rule, we proposed to assign CPT code 47384 and CPT code 55877 to APC 5362 and status indicator J1
For a broader comparison between the two major GLP-1 medications, see our semaglutide versus tirzepatide comparison
However, the data indicates that this peptide might not significantly affect the frequency of growth hormone pulses or the peak levels reached during each pulse
Your healthcare provider will need to document that you still meet all four of the aforementioned requirements, plus one new requirement: that youve lost at least 5% of your body weight since starting treatment with Zepbound
Hepatology .2026;[Epub] CrossRef Updates on paediatric MASLD: insights from an endocrine lens Natalie Segev, Marialena Mouzaki Diabetologia .2026;[Epub] CrossRef An Integrated NanozymeExosome Platform for MultiTargeted Therapy of MetabolicAssociated Steatotic Liver Disease Kun Yu, Xinwei Li, Yingying Liu, Haonan Zhang, Guojie Liu, Tuo Ji, Yuzhi Gao, Lin Wang, Yuwei Bian, Guohua Chen, Zhiwen Zhao, Feng Wang, Xiaoming Yu, Jiachen He, Xuzhu Gao Advanced Healthcare Materials .2026;[Epub] CrossRef Safety and efficacy of pharmacological interventions for hepatic outcomes of metabolic dysfunction-associated steatotic liver disease: protocol for systematic review and network meta-analysis Kiavash Semnani, Farbod Semnani, Seyed Sahab Aarabi, Shirin Esmaeili, Ehsaneh Taheri, Armita Mahdavi-Gorabi, Mohsen Rajabnia, Shirin Djalalinia, Saba Goodarzi, Amir Kasaeian, Mohammad Shadab Siddiqui, Mostafa Qorbani BMJ Open .2026
